Droplet-scale estrogen assays in breast tissue, blood, and serum
- PMID: 20368154
- DOI: 10.1126/scitranslmed.3000105
Droplet-scale estrogen assays in breast tissue, blood, and serum
Abstract
Estrogen is a key hormone in human reproductive physiology, controlling ovulation and secondary sexual characteristics. In addition, it plays an important role in the pathogenesis of breast cancer. Indeed, estrogen receptor antagonists and aromatase inhibitors (which block estrogen biosynthesis) are primary drugs used for treatment and prevention in at-risk populations. Despite its importance, tissue concentrations of estrogen are not routinely measured because conventional techniques require large samples of biopsies for analysis. In response to this need, we have developed a digital microfluidic method and applied it to the extraction and quantification of estrogen in 1-microliter samples of breast tissue homogenate (as would be collected with fine-needle aspiration), as well as in whole blood and serum. This method may be broadly applicable to conditions requiring frequent analysis of hormones in clinical samples (for example, infertility and cancer).
Similar articles
-
Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):221-36. doi: 10.1016/j.jsbmb.2005.02.007. J Steroid Biochem Mol Biol. 2005. PMID: 15860265 Review.
-
Impact of estrogen deprivation on gene expression profiles of normal postmenopausal breast tissue in vivo.Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):855-63. doi: 10.1158/1055-9965.EPI-07-2718. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398027
-
Pomegranate and breast cancer: possible mechanisms of prevention.Nutr Rev. 2010 Feb;68(2):122-8. doi: 10.1111/j.1753-4887.2009.00268.x. Nutr Rev. 2010. PMID: 20137057 Review.
-
Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.Cancer Res. 2000 Mar 15;60(6):1604-8. Cancer Res. 2000. PMID: 10749129
-
Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1067-73. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578144
Cited by
-
Microfluidics and cancer: are we there yet?Biomed Microdevices. 2013 Aug;15(4):595-609. doi: 10.1007/s10544-012-9734-8. Biomed Microdevices. 2013. PMID: 23358873 Free PMC article. Review.
-
Microfluidics - The State-of-the-Art Technology for Pharmaceutical Application.Adv Pharm Bull. 2022 Aug;12(4):700-711. doi: 10.34172/apb.2022.073. Epub 2021 Sep 29. Adv Pharm Bull. 2022. PMID: 36415637 Free PMC article. Review.
-
A Review on Microfluidics: An Aid to Assisted Reproductive Technology.Molecules. 2021 Jul 19;26(14):4354. doi: 10.3390/molecules26144354. Molecules. 2021. PMID: 34299629 Free PMC article. Review.
-
Point-of-care technologies for molecular diagnostics using a drop of blood.Trends Biotechnol. 2014 Mar;32(3):132-9. doi: 10.1016/j.tibtech.2014.01.003. Epub 2014 Feb 11. Trends Biotechnol. 2014. PMID: 24525172 Free PMC article. Review.
-
Droplet dispensing in digital microfluidic devices: Assessment of long-term reproducibility.Biomicrofluidics. 2012 Jun;6(2):22003-2200310. doi: 10.1063/1.3693592. Epub 2012 Apr 6. Biomicrofluidics. 2012. PMID: 22655007 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources